Introduction
============

Putrescine (1,4-diaminobutane) is widely used as a building block for the industrial production of bioplastics, pharmaceuticals, agrochemicals, and surfactants. For example, putrescine is a raw material used in the production of the bioplastic polyamide nylon-4,6 via polycondensation with adipic acid. Nylon-4,6 is a superior engineering plastic due to its high melting point, high mechanical strength, and excellent solvent resistance. The demand for putrescine is approximately 10,000 tons per year in Europe and is expected to grow ([@B33]).

The potential commercial demands mean that the efficient biotechnological production of putrescine has become increasingly necessary. After introducing an ornithine decarboxylase gene, putrescine has been produced using engineered *Escherichia coli* ([@B27]) and *Corynebacterium glutamicum* ([@B30]). An engineered *E. coli* XQ52 (p15SpeC) strain was constructed for putrescine production by a combination of deleting endogenous degradation pathways and replacing the native promoters of the ornithine biosynthetic genes. The strain produced 1.68 g/L of putrescine with a yield of 0.166 g/g glucose in a shake-flask fermentation and 24.2 g/L with a productivity of 0.75 g/L.h in a 6.6-L fed-batch fermentation ([@B27]). The Wendisch group constructed a series of engineered *C. glutamicum* strains for putrescine production ([@B30]; [@B29]; [@B7]; [@B22],[@B23]). Their strategies included: (1) lowering the ornithine carbamoyltransferase gene (*argF*) expression by modifications of the *argF* promoter, translational start codon, and ribosome-binding site ([@B7]); (2) reducing α-ketoglutarate decarboxylase (Kgd) activity by replacing the *kgd* native start codon GTG with TTG and the native *odhI* gene with the *odhI^T15A^* gene; (3) deleting the *snaA* gene to eliminate putrescine acetylation ([@B23]); (4) overexpression of the putrescine transporter gene (*cgmA*), the glyceraldehyde 3-phosphate dehydrogenase gene (*gap*), the pyruvate carboxylase gene (*pyc*) and the feedback-resistant *N*-acetylglutamate kinase variant gene (*argB*^A49V/M54V^). The final engineered *C. glutamicum* strain NA6 produced 58.1 mM (5.1 g/L) of putrescine with a yield on glucose of 0.26 g/g in a flask culture ([@B22]), representing the highest values yet seen. The titer and yield of *C. glutamicum* NA6 were 1.99- and 2-fold higher than that of the parent strain *C. glutamicum* PUT21 ([@B22]), respectively. The parent strain *C. glutamicum* PUT21 produced 19 g/L putrescine with a productivity of 0.55 g/L/h and a yield 0.166 g/g glucose in a fed-batch fermentation ([@B29]).

Although engineered *C. glutamicum* has been successfully employed for the high-level production of putrescine, the overall cellular physiological and metabolic changes caused by the overproduction of putrescine remain unclear. Transcriptome analysis has become an effective approach for monitoring cellular physiological and metabolic changes ([@B36]). Detailed information on cellular physiological changes cannot only allow for a much better understanding of the underlying regulatory mechanisms but also provide new genetic modification strategies for the further improvement in the production of metabolites. Thus, to understand the cellular physiological and metabolic changes occurring in response to the overproduction of putrescine, we carried out a comparative transcriptomic analysis between the putrescine-producer *C. glutamicum* PUT-ALE and the wild-type strain *C. glutamicum* ATCC 13032.

Materials and Methods {#s1}
=====================

Strains, Plasmids, and Primers
------------------------------

The bacterial strains used in this study are listed in **Table [1](#T1){ref-type="table"}**. Plasmids and primers used in this study are presented in Supplementary Table [1](#SM1){ref-type="supplementary-material"}.

###### 

Strains used in this study.

  Name                                      Description                                                                                                                                            Reference/Sources
  ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------
  Strains                                                                                                                                                                                          
  *Corynebacterium glutamicum* ATCC 13032   Wild-type                                                                                                                                              ATCC
  *C. glutamicum* ΔAPE6937R42               Ornithine producing strain, the evolved strain of *C. glutamicum* ATCC 13032 (Δ*argF*Δ*proB*Δ*speE*), Δ*argR*                                          [@B13]
  *C. glutamicum* PUT-ALE                   Putrescine producer, the metabolically evolved strain of *C. glutamicum* ΔAPE6937R42 with Δ*puo*, Δ*fabG*:: P~H36~-*speC1~ECL~*, Δ*butA* and Δ*snaA*   Lab storage
  *C. glutamicum* PUT-ALE-KT                Putrescine producer, the *kgd* native GTG start codon in *C. glutamicum* PUT-ALE was replaced with TTG.                                                This study

Plasmid Construction
--------------------

Genes were amplified from genomes using the responding primers (Supplementary Table [1](#SM1){ref-type="supplementary-material"}) and cloned into pEC-XK99E ([@B19]). Gene disruption was performed via two-step homologous recombination using the non-replicable integration vector pK-JL as described by [@B13],[@B14])).

To enhance specificity and reduce off-target effects, the *dcas9* on pCRISPathBrick ([@B9]) was site-directed mutated into *dcas9 (K848A/K1003A/R1060A)* as described as [@B35] to obtain pCRISPathBrick^∗^. The p15A *ori* was amplified from pBAD33 ([@B10]) using P15AF and P15AR. The vector backbone was amplified from pEC-XK99E ([@B19]) using primer PEC-AF and PEC-AR. The two PCR products were recombined using ClonExpress II One Step Cloning Kit (Vazyme Biotech Co., Ltd., Nanjing, China) to obtain pEC-XK-p15A. The *dcas9^∗^* gene was amplified from pCRISPathBrick^∗^ using primers dcas9^∗^F and dcas9^∗^R and then cloned into the *XmaI/XbaI* sites of pEC-XK-p15A to generate pEC-dcas9^∗^ (Supplementary Figure [1A](#SM2){ref-type="supplementary-material"}). The sgRNA sequence was amplified from pTargetF ([@B15]) using primers sgRNAF and sgRNAR. The vector backbone was amplified from pXMJPsod using primers psodGF and psodGR. The two PCR products were recombined using ClonExpress II One Step Cloning Kit to obtain the sgRNA plasmid pXMJPsod-sgRNA.

The pXMJPsod-X-sgRNA series (Supplementary Figure [1B](#SM2){ref-type="supplementary-material"}), used in target single-gene repression with a targeting N20 sequence of gene loci of interest, was obtained by inverse PCR using primes the target N20F and PsodG-R from pXMJPsod-sgRNA, and followed by self-ligation.

Putrescine Production in Shake Flasks
-------------------------------------

A single colony was inoculated into 5 mL of seed medium in a test tube, which was aerobically cultured overnight at 200 rpm and 30°C. The overnight seed culture was used to inoculate 50 mL of fermentation medium with an initial OD~600~ of 0.2. The primary cultures were incubated at 30°C for 72 h in a rotary shaking incubator at 200 rpm. Each liter of seed medium contained 25 g of glucose, 10 g of yeast extract, 10 g of corn steep liquor, 15 g of (NH~4~)~2~SO~4~, 2.5 g of MgSO~4~ 7H~2~O, 1 g of KH~2~PO~4~, 0.5 g of K~2~HPO~4~, 0.5 g of Na~2~HPO~4~, and 10 g of CaCO~3~. Each liter of fermentation medium contained 100 g of glucose, 20 g of corn steep liquor, 50 g of (NH~4~)~2~SO~4~, 2.5 g of MgSO~4~ 7H~2~O, 1 g of KH~2~PO~4~, 0.5 g of K~2~HPO~4~, 0.5 g of Na~2~HPO~4~, 20 mg of FeSO~4~ 7H~2~O, 20 mg of MnSO~4~ 4H~2~O, 2 g of molasses, 1 mL of Tween-80, and 10 g of CaCO~3~. The initial pH of both media described above was adjusted to 7.0.

Analysis of Growth and Metabolite Concentration
-----------------------------------------------

Growth was monitored by measuring the optical density of the culture at 600 nm after adding 0.2 M HCl to dissolve CaCO~3~. The glucose concentration was determined using glucose oxidase and a glucose assay kit (Shanghai Rongsheng Biotech Corporation, Shanghai, China). The putrescine concentration was determined using a Shimadzu HPLC system (LC-20A HPLC, Shimadzu, Japan) equipped with an Inertsil ODS-SP column (5 μm, 4.6 mm × 150 mm, GL Sciences Inc., Tokyo, Japan) as described by [@B30]. Putrescine was first derivatized using 9-fluorenylmethyl chloroformate (FMOC). The fluorescent derivatives were detected by excitation at 263 nm (emission at 310 nm). The mobile phase consisted of solvent A (0.05 M sodium acetate, pH 4.2) and solvent B (acetonitrile) with a flow rate of 1.3 mL/min. The following gradient was used: 0 min, 38% B; 5 min, 38% B; 12 min, 57% B; 14 min, 57% B; 20 min, 65% B; 25 min, 76% B; and 35 min, 76% B. A standard curve was constructed from serial dilutions of a standard stock solution of 1,4-diaminobutane.

Transcriptome Analysis
----------------------

RNA-Seq was performed by GENWIZ (Shuzhou, China) using an Illumina HiSeq sequencer (Illumina, San Diego, CA, United States). Each sample was analyzed in duplicate. Cells cultured for 48 h were harvested by centrifugation at 300 rpm for 2 min to remove CaCO~3~ and then at 5,000 × *g* for 15 min and washed twice with PBS. Total RNA was extracted using TRIzol Reagent (Invitrogen) and an RNeasy Mini Kit (Qiagen). Total RNA from each sample was quantified and qualified by an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, United States), NanoDrop (Thermo Fisher Scientific Inc.) and a 1% agarose gel. One μg of total RNA with RIN values above 7 was used for following library preparation. Next generation sequencing library preparations were performed according to the manufacturer's protocol (NEBNext^®^ Ultra^TM^ Directional RNA Library Prep Kit for Illumina^®^). The rRNA was depleted from the total RNA using a Ribo-Zero rRNA Removal Kit (Bacteria) (Illumina). The rRNA-depleted mRNA was then fragmented and reverse-transcribed. First-strand cDNA was synthesized using ProtoScript II Reverse Transcriptase with random primers and Actinomycin D. The second-strand cDNA was synthesized using Second Strand Synthesis Enzyme Mix (including dACG-TP/dUTP). The double-stranded cDNA was purified using an AxyPrep Mag PCR Clean-up kit (Axygen) and was then treated with End Prep Enzyme Mix to repair both ends and perform dA-tailing of cDNA in one reaction, followed by a T-A ligation to add adaptors to both ends. Size selection of adaptor-ligated DNA was then performed using an AxyPrep Mag PCR Clean-up kit (Axygen)to recover ∼360 bp fragments (with approximate insert sizes of 300 bp). The dUTP-marked second strand was digested with Uracil-Specific Excision Reagent (USER) enzyme (New England Biolabs). Each sample was then amplified by PCR for 11 cycles using P5 and P7 primers, with both primers carrying sequences that can anneal with the flow cell to perform bridge PCR and the P7 primer carrying a six-base index allowing for multiplexing. The PCR products were purified using an AxyPrep Mag PCR Clean-up kit (Axygen), validated using an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, United States), and quantified with a Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, United States). Next, libraries with different indices were multiplexed and loaded onto an Illumina HiSeq instrument according to the manufacturer's instructions (Illumina, San Diego, CA, United States). Sequencing was carried out using a 2x150 paired-end (PE) configuration; image analysis and base calling were conducted using the HiSeq Control Software (HCS) + OLB + GAPipeline-1.6 (Illumina) on the HiSeq instrument. The sequences were processed and analyzed by GENEWIZ.

Raw data were processed to generate the pass filter data by Bcl2fastq (v 2.17.1.14), quality checked using the FastQC (v 0.10.1) tool and finally filtered to prepare the clean reads using Cutadapt (v 1.9.1). The clean data were aligned to the reference genome of *C. glutamicum* ATCC 13032 (Uniprot: UP000000582) using Bowtie 2 (v 2.1.0^[1](#fn01){ref-type="fn"}^). The gene transcript expression levels were calculated using HTSeq (v 0.6.1p1) ([@B2]) and then normalized based on the FPKM (fragments per kilobase of exon per million fragments mapped) method. A false-discovery rate of ≤0.05 ([@B4]) and the absolute value of the log~2~ ratio ≥ 1 were applied as threshold values to define a significant difference in gene expression levels using the DESeg2 (v1.6.3) in Bioconductor package ([@B1]). GO-TermFinder (v0.86) ([@B5]) was used in identifying Gene Ontology (GO) terms to annotate a list of enriched genes with a significant *p*-value of less than 0.05.

Raw sequence data were deposited in the NCBI Sequence Read Archive database (SRA) under the accession number of [SRP117800](SRP117800).

Results and Discussion
======================

Culturing of *C. glutamicum* PUT-ALE and Its Parent Strain *C. glutamicum* ΔAPE6937R42
--------------------------------------------------------------------------------------

In our previous study, we constructed the *C. glutamicum* PUT-ALE strain from the ornithine producer *C. glutamicum* ΔAPE6937R42 ([@B13]) for putrescine production using a metabolic evolution strategy (Supplementary Text). We first compared the growth, glucose consumption, and putrescine production of the *C. glutamicum* PUT-ALE and the wild-type strain *C. glutamicum* ATCC 13032 strains. As shown in **Figure [1](#F1){ref-type="fig"}**, *C. glutamicum* PUT-ALE produced a higher level of putrescine than the wild-type strain *C. glutamicum* ATCC 13032. Interestingly, *C. glutamicum* PUT-ALE (μ = 0.38 h^-1^) showed a lower growth rate than *C. glutamicum* ATCC 13032 (μ = 0.43 h^-1^). This may be because *C. glutamicum* PUT-ALE and its parent strain *C. glutamicum* ΔAPE6937R42 are [L]{.smallcaps}-arginine and [L]{.smallcaps}-proline auxotrophs, resulting from knockouts of the *argF* and *proB* genes ([@B13],[@B14]). The rate of glucose consumption by *C. glutamicum* PUT-ALE was similar to that of the wild-type strain ATCC 13032.

![The growth **(A)**, glucose consumption **(B)** and putrescine production **(C)** in *Corynebacterium glutamicum* PUT-ALE (•) and ATCC 13032 (∘). Data represent the average of three replicates and error bars represent standard deviation.](fmicb-08-01987-g001){#F1}

Transcriptomic Changes
----------------------

To identify the cellular physiological and metabolic changes occurring in response to the overproduction of putrescine, we analyzed the transcriptomic changes between the putrescine-producer *C. glutamicum* PUT-ALE and the wild-type strain *C. glutamicum* ATCC13032. The putrescine production resulted in the differential expression of 607 genes, of which 283 were upregulated and 324 were downregulated (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). We also analyzed the transcriptomic changes between the putrescine-producer *C. glutamicum* PUT-ALE and its parent strain *C. glutamicum* ΔAPE6937R42. A total of 269 genes showed significantly different expression patterns (Supplementary Table [3](#SM1){ref-type="supplementary-material"}). Of them, only 29 genes were related to metabolism. Thus, we focused on differentially expressed genes (DEGs) between *C. glutamicum* PUT-ALE and the wild-type strain *C. glutamicum* ATCC13032 in this study.

The GO project provides a controlled vocabulary to describe gene products within three categories: biological process, molecular function and cellular component ([@B5]). GO enrichment analysis has become a commonly used approach for functional studies, and the GO analysis of DEGs can help biologists better understand the functional relevance of DEGs. In **Figure [2](#F2){ref-type="fig"}**, the results of a GO analysis of DEGs for *C. glutamicum* PUT-ALE vs. ATCC 13032 is presented.

![Pathway gene ontology enrichment analysis. **(A)** The ratio of the DEGs in the total number of genes detected. **(B)** The numbers of the DEGs.](fmicb-08-01987-g002){#F2}

DEGs involved in metabolic pathways are presented in **Figures [3](#F3){ref-type="fig"}** and **[4](#F4){ref-type="fig"}**. As shown in **Figure [3](#F3){ref-type="fig"}**, most of the genes (*glpX, fda, gpmB, eno, pyk, aceE, prpC1, acn, kgd, sdhAB, mdh, aceAB*) involved in the glycolysis and tricarboxylic acid (TCA) cycle were significantly downregulated in *C. glutamicum* PUT-ALE compared to *C. glutamicum* ATCC13032. The low rate of growth of *C. glutamicum* PUT-ALE is consistent with the observed downregulated data. The *pyc* gene in *C. glutamicum* PUT-ALE was also downregulated. The pyruvate carboxylase encoded by *pyc* is one of the most important anaplerotic enzymes in *C. glutamicum*. Overexpression of the *pyc* gene can drive greater EMP flux into the TCA cycle to strengthen it. It has been demonstrated that overexpression of the *pyc* gene increased [L]{.smallcaps}-glutamate ([@B34]; [@B11]), [L]{.smallcaps}-arginine ([@B21]) and putrescine ([@B22]) production in *C. glutamicum*. Thus, we expressed *pyc* or its mutant *pyc458* from a plasmid in *C. glutamicum* PUT-ALE. As shown in **Table [2](#T2){ref-type="table"}**, overexpression of the native *pyc* gene slightly increased putrescine production, while overexpression of the mutated *pyc458* gene markedly increased putrescine production by 16% to 133.51 ± 7.20 mM. It has been reported that *pyc458* is a beneficial mutation for [L]{.smallcaps}-lysine production ([@B25]).

![Differentially expressed genes involved in glycolysis, the TCA cycle, pyruvate metabolism, amino acid biosynthesis and the putrescine biosynthetic pathway. The numbers indicate the values of the log~2~ ratios of the expression levels in *C. glutamicum* PUT-ALE vs. *C. glutamicum* ATCC 13032. Red indicates upregulation. Blue indicates downregulation. Glc, glucose; G6P, glucose 6-phosphate; F6P, fructose 6-phosphate; F1,6P, fructose 1,6-bisphosphate; GAP, [D]{.smallcaps}-Glyceraldehyde 3-phosphate; GlyP, glycerone phosphate; G1,3P, 1,3-bisphospho-[D]{.smallcaps}-glycerate; G3P, 3-phosphoglycerate; G2P, 2-phospho-(R)-glycerate; PEP, phosphoenolpyruvate; Pyr, pyruvate; AcCoA, acetyl-CoA; GlcLac, [D]{.smallcaps}-glucono-1,5-lactone 6-phosphate; 6-*P*-glucon, 6-phospho-[D]{.smallcaps}-gluconate; Ribu5P, [D]{.smallcaps}-Ribulose 5-phosphate; Rib5P, [D]{.smallcaps}-ribose 5-phosphate; Xyl5P, [D]{.smallcaps}-Xylulose 5-phosphate; S7P, [D]{.smallcaps}-sedoheptulose 7-phosphate; E4P, [D]{.smallcaps}-erythrose 4-phosphate; PRPP, 5-phosphoribosyl diphosphate; His, [L]{.smallcaps}-histidine; DAHP, 3-deoxy-arabino-heptulonate 7-phosphate; Trp, [L]{.smallcaps}-tryptophan; Phe, [L]{.smallcaps}-phenylalanine; Tyr: [L]{.smallcaps}-tyrosine; [D]{.smallcaps}-Lac, [D]{.smallcaps}-Lactate; [L]{.smallcaps}-Lac, [L]{.smallcaps}-lactate; Ace, acetate; Val, [L]{.smallcaps}-valine; Ile, [L]{.smallcaps}-isoleucine; Leu, [L]{.smallcaps}-leucine; Ser, [L]{.smallcaps}-serine; Gly, [L]{.smallcaps}-glycine; Cys, [L]{.smallcaps}-cysteine; Ala, [L]{.smallcaps}-alanine; Cit, citrate; Ici, isocitrate; KG, 2-oxoglutarate; SucCoA, succinyl-CoA; Suc, succinate; Fum, fumarate; Mal, malate; OAA, oxaloacetate; Asp, [L]{.smallcaps}-aspartate; Asn, [L]{.smallcaps}-asparagine; ASA, L-aspartate 4-semialdehyde; HTPA, (2S,4S)-4-hydroxy-2,3,4,5-tetrahydrodipicolinate; Lys, [L]{.smallcaps}-lysine; Hom, homoserine; Thr, [L]{.smallcaps}-threonine; Ac-Hom, *O*-acetylhomoserine; Homcys, [L]{.smallcaps}-homocysteine; Met, [L]{.smallcaps}-methionine. Glut, [L]{.smallcaps}-glutamate; Gln, [L]{.smallcaps}-glutamine; GlutP, [L]{.smallcaps}-glutamate 5-phosphate; NAGlut, *N*-acetylglutamate; NAGlutP, *N*-acetyl-glutamyl 5-phosphate; NAGlut-semialdehyde, *N*-acetylglutamate semialdehyde; NAOrn, *N*-acetyl-ornithine; Orn, ornithine; Arg, [L]{.smallcaps}-arginine.](fmicb-08-01987-g003){#F3}

![The relative transcriptional levels of genes involved in oxidative phosphorylation **(A)**, vitamin biosynthesis **(B)**, the metabolism of purine and pyrimidine **(C)**, and sulfur metabolism **(D)**.](fmicb-08-01987-g004){#F4}

###### 

Effect of the *pyc* and *kgd* gene on putrescine production in *C. glutamicum* PUT-ALE.

  Strain                                 OD~600~        Putrescine (mM)   Yield (%, g/g)
  -------------------------------------- -------------- ----------------- ----------------
  *C. glutamicum* PUT-ALE (pEC-XK99E)    19.41 ± 0.75   115.12 ± 2.42     27.0 ± 0.1
  *C. glutamicum* PUT-ALE (pEC-pyc)      15.93 ± 0.35   123.18 ± 2.71     27.3 ± 0.6
  *C. glutamicum* PUT-ALE (pEC-pyc458)   16.98 ± 0.44   133.51 ± 7.20     28.1 ± 1.5
  *C. glutamicum* PUT-ALE                17.64 ± 0.27   107.95 ± 2.31     27.6 ± 1.1
  *C. glutamicum* PUT-ALE-KT             20.04 ± 0.78   114.39 ± 2.14     28.4 ± 1.5

Data represent the average of three replicates and error bars represent standard deviation.

The transcription level of the *kgd* gene was also downregulated in *C. glutamicum* PUT-ALE. Alpha-ketoglutarate (KG) is a key node of the TCA cycle, and α-ketoglutarate decarboxylase (encoded by *kgd*) catalyzes the oxidative decarboxylation of KG to synthesize succinyl coenzyme A. The downregulation of *kgd* transcription can channel increased carbon flux into the glutamate biosynthetic pathway, enhancing putrescine production. Many groups have reported that decreasing the Kgd activity in *Corynebacterium*, or even deleting *kgd*, increased the production of glutamate ([@B3]; [@B17]), the glutamate-derived compound putrescine ([@B22]), gamma-aminobutyric acid ([@B16]) and [L]{.smallcaps}-arginine ([@B6]; [@B21]). It has been demonstrated that the exchanging the translational start codon of the *kgd* gene from GTG to TTG reduced the Kgd activity from 11 to 7 mU/mg ([@B22]). Thus, we replaced the native GTG start codon of the *C. glutamicum* PUT-ALE *kgd* gene with TTG to obtain *C. glutamicum* PUT-ALE-KT. The resulting strain (*C. glutamicum* PUT-ALE-KT) produced a higher level of putrescine (114.39 ± 2.14 mM) than *C. glutamicum* PUT-ALE (107.95 ± 2.31, **Table [2](#T2){ref-type="table"}**), indicating that decreasing the activity of Kgd may be a strategy for further improving putrescine production.

In **Figure [3](#F3){ref-type="fig"}**, it is observed that may genes that are involved in pyruvate metabolism were significantly down-regulated in *C. glutamicum* PUT-ALE, such as *ldh, lldD, pox, eutD, acyP*, and *ackA*. The downregulation of pyruvate metabolism can drive carbon flux toward glycolysis for putrescine biosynthesis. Genes involved in the putrescine biosynthetic pathway, such as *argJ, argB, argC*, and *argD* were significantly upregulated in *C. glutamicum* PUT-ALE (**Figure [3](#F3){ref-type="fig"}**).

We also observed that some genes involved in the serine, methionine, histidine, tryptophan, and tyrosine biosynthetic pathway were significantly downregulated (**Figure [3](#F3){ref-type="fig"}**). These genes include *serA, serC, metB, metY, metE, metH, hisB, hisC, hisD, aroD, trpC, trpB, trpA*, and *tyrA.* The enzyme encoded by *serC* or *hisC* catalyzes the glutamate-consuming reaction. The downregulation of *serC* and *hisC* transcription may provide more glutamate for putrescine biosynthesis.

As shown in **Figure [4A](#F4){ref-type="fig"}**, the transcriptional levels of genes involved in oxidative phosphorylation were down-regulated, such as *sdhA, sdhB, qcrB, coxC, coxA, cydA*, and *cydB*. Genes involved in thiamine and vitamin B6 biosynthesis, such as *thiG, thiO, thiC, thiM, thiDE*, and *thiD2*, were also down-regulated (**Figure [4B](#F4){ref-type="fig"}**). The transcriptional levels of genes involved in purine and pyrimidine metabolism, such as *relA, purH, purL, guaA*, and *purF* were down-regulated (**Figure [4C](#F4){ref-type="fig"}**), as were genes involved in sulfur metabolism, such as *cysH, ssuD1, thiF, thiS, moeZR, moaC*, and *moaE* (**Figure [4D](#F4){ref-type="fig"}**). Of the above genes, *thiM, thiDE, thiD2, relA, purl, guaA*, and *moeZR* encode adenosine triphosphate (ATP)-consuming enzymes. The transcriptional downregulation of these genes could result in more ATP being available for putrescine production.

ATP is the most important energy source for metabolic reaction and pathways, playing an important role in cell growth and the production of target metabolites. Many ATP-consuming enzyme encoding genes, such as *rbsK, cysD, cysN, pknG, pknB, bioD, iolC, mthfs, coaE, chlI, glgC*, and *moeZR*, were downregulated in *C. glutamicum* PUT-ALE (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). It has been reported that increasing the ATP supply enhanced L-arginine production in *C. glutamicum* ([@B20]). The protein kinases encoded by *pknG* and *pknB* phosphorylate the α-ketoglutarate decarboxylase inhibitor OdhI, and unphosphorylated OdhI inhibits α-ketoglutarate decarboxylase activity ([@B24]; [@B32]; [@B28]). Thus, the decreased transcription of *pknG* and *pknB* in *C. glutamicum* PUT-ALE may increase the ability of OdhI to inhibit α-ketoglutarate decarboxylase. The regulation of OdhI phosphorylation by the deletion of the protein kinase encoding gene *pknG* has been previously shown to increase glutamate production ([@B31]).

In **Figure [3](#F3){ref-type="fig"}**, it is observed that synthesizing one mole of putrescine requires 2 moles of NADPH and 5 moles of NAD. Thus, NADPH availability and transhydrogenation between NAD and NADP are important for putrescine production. The transcriptional levels of the NADPH-consuming enzyme encoding genes \[*rhcM2* and NAD (FAD)-dependent dehydrogenase gene *NCgl2615*\] and the NAD-consuming enzyme encoding genes (*gabD3, iolG*, and *fdhF*) were significantly downregulated. The transcriptional levels of NADPH-forming enzyme encoding genes, such as *proA, aldH*, and *mdhB*, were significantly upregulated in *C. glutamicum* PUT-ALE (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). The expression patterns can increase NADPH or NAD availability for putrescine production. It has been demonstrated that increasing NADPH availability enhances [L]{.smallcaps}-ornithine production ([@B14]; [@B12]; [@B18]).

CRISPRi system is a powerful tool to repress expression of targeted genes ([@B26]). It has successfully applied to repress genes for improving [L]{.smallcaps}-lysine and [L]{.smallcaps}-glutamate production in *C. glutamicum* ([@B8]). Thus, we established a CRISPRi system, which contains the *dcas9 (K848A/K1003A/R1060A)* plasmid pEC-dcas9^∗^ (Supplementary Figure [1A](#SM2){ref-type="supplementary-material"}) and the sgRNA plasmid pXMJPsod-X-sgRNA (Supplementary Figure [1B](#SM2){ref-type="supplementary-material"}). To validate the effects of ATP- and NADPH-consuming enzyme genes, we applied the CRISPRi system to repress expression of ATP- and NADPH-consuming enzyme encoding genes in *C. glutamicum* PUT-ALE. The results were presented in **Table [3](#T3){ref-type="table"}**. Repressing ATP-consuming enzyme encoding genes, such as *carB, xylB, accDA, purL, coaA, pknG*, and *panC2* resulted in increasing putrescine production of 5--10%. Repressing the *dxr, aroE*, or *trxB* expression enhanced putrescine production by 13, 19, or 20%, respectively. The *dxr* encodes 1-deoxy-[D]{.smallcaps}-xylulose 5-phosphate reductoisomerase which catalyzes the reduction of 1-deoxy-D-xylulose 5-phosphate to 2-C-methyl-[D]{.smallcaps}-erythritol 4-phosphate in the presence of NADPH. The *aroE* encodes shikimate dehydrogenase which catalyzes NAD^+^-dependent oxidation of shikimate to 3-dehydroshikimate. The *trxB* encodes thioredoxin reductase which catalyzes the reduction of thioredoxin disulfide to thioredoxin in the presence of NADPH. Repressing the *dxr, trxB*, or *aroE* expression can provide more NADPH or NAD for putrescine production.

###### 

Effect of perturbations of ATP- and NADPH-consuming enzyme encoding genes on putrescine production in *C. glutamicum* PUT-ALE.

  Gene targeted         Gene encoding enzyme/protein                                                                    OD~600~        Putrescine (mM)   Ratio
  --------------------- ----------------------------------------------------------------------------------------------- -------------- ----------------- -------
  **ATP-consuming**                                                                                                                                      
  Control                                                                                                               16.83 ± 0.18   103.66 ± 3.29     1.00
  *carB*                Carbamoyl-phosphate synthase large subunit \[EC6.3.5.5\]                                        17.27 ± 0.20   109.00 ± 4.36     1.05
  *thrB1*               Homoserine kinase \[EC 2.7.1.39\]                                                               17.02 ± 0.20   105.05 ± 0.45     1.01
  *coaA*                Pantothenate kinase \[EC 2.7.1.33\],                                                            16.56 ± 0.51   110.18 ± 1.32     1.06
  *glnA*                Glutamine synthetase \[EC 6.3.1.2\]                                                             15.63 ± 0.06   86.44 ± 5.17      0.86
  *nadD*                Nicotinate-nucleotide adenylyltransferase \[EC 2.7.7.18\]                                       16.71 ± 0.18   95.68 ± 0.93      0.92
  *hemH*                Phosphoribosylaminoimidazole-succinocarboxamide synthase \[EC 6.3.2.6\],                        16.55 ± 0.35   86.74 ± 8.33      0.84
  *xylB*                Xylulokinase \[EC 2.7.1.17\]                                                                    16.62 ± 0.42   108.88 ± 0.07     1.05
  *guaA*                GMP synthase (glutamine-hydrolysing) \[EC:6.3.5.2\],                                            17.25 ± 0.24   82.71 ± 1.40      0.80
  *accBC*               Acyl-CoA carboxylase                                                                            18.26 ± 0.42   80.20 ± 0.55      0.77
  *accDA*               Acetyl-CoA carboxylase beta subunit \[EC 6.4.1.2\]                                              17.36 ± 0.10   109.24 ± 0.04     1.05
  *purL*                Phosphoribosylformylglycinamidine synthase \[EC 6.3.5.3\]                                       16.60 ± 0.54   108.86 ± 0.59     1.05
  *purQ*                Phosphoribosylformylglycinamidine synthase \[EC 6.3.5.3\]                                       17.91 ± 0.38   103.78 ± 5.31     1.00
  *panC1*               Pantoate-beta-alanine ligase \[EC 6.3.2.1\]                                                     18.98 ± 1.34   107.24 ± 0.98     1.03
  *panC2*               Pantoate-beta-alanine ligase \[EC 6.3.2.1\]                                                     17.98 ± 0.58   113.94 ± 2.98     1.10
  *pknG*                Serine/threonine protein kinases \[EC 2.7.11.1\]                                                17.59 ± 0.35   109.57 ± 1.21     1.06
  **NADPH-consuming**                                                                                                                                    
  Control                                                                                                               19.80 ± 0.30   108.99 ± 2.51     1.00
  *pobA*                *p*-hydroxybenzoate 3-monooxygenase \[EC 1.14.13.2\]                                            15.90 ± 0.24   105.36 ± 2.53     0.93
  *aldH*                2,5-dioxopentanoate dehydrogenase \[EC 1.2.1.26\]                                               16.07 ± 0.15   92.65 ± 3.83      0.88
  *fabG1*               3-oxoacyl-\[acyl-carrier protein\] reductase \[EC 1.1.1.100\],                                  16.08 ± 0.26   108.96 ± 0.79     0.96
  *adhC*                Maleylacetate reductase \[EC 1.3.1.32\]                                                         15.62 ± 0.16   101.45 ± 2.38     0.93
  *gor*                 Dihydrolipoamide dehydrogenase/glutathione oxidoreductase and related enzymes, \[EC 1.8.1.7\]   15.52 ± 0.35   94.92 ± 3.05      0.87
  *dxr*                 1-deoxy-D-xylulose-5-phosphate reductoisomerase \[EC 1.1.1.267\]                                15.36 ± 0.50   123.18 ± 0.55     1.13
  *asd*                 aspartate-semialdehyde dehydrogenase \[EC 1.2.1.11\]                                            15.54 ± 0.18   99.7 ± 1.48       0.91
  *proA*                Glutamate-5-semialdehyde dehydrogenase \[EC 1.2.1.41\]                                          16.21 ± 0.19   98.51 ± 0.87      0.90
  *NCgl2558*            Transcriptional regulators                                                                      15.87 ± 0.12   99.06 ± 1.92      0.87
  *thyX*                Thymidylate synthase (FAD) \[EC 2.1.1.148\]                                                     19.77 ± 0.48   103.71 ± 3.55     0.95
  *aroE*                Shikimate dehydrogenase \[EC 1.1.1.25\],                                                        16.74 ± 0.06   129.29 ± 1.76     1.19
  *sir*                 Sulfite reductase (ferredoxin) \[EC 1.8.7.1\]                                                   17.82 ± 0.30   106.87 ± 2.02     0.98
  *NCgl0503*            Aldo/keto reductases                                                                            15.18 ± 2.58   110.53 ± 3.30     1.01
  *ddh*                 diaminopimelate dehydrogenase \[EC 1.4.1.16\]                                                   15.93 ± 0.09   98.82 ± 2.68      0.91
  *ilvC*                Ketol-acid reductoisomerase \[EC 1.1.1.86\]                                                     16.32 ± 0.30   102.49 ± 3.71     0.94
  *qor*                 NADPH:quinone reductase and related Zn-dependent oxidoreductases \[EC 1.6.5.5\]                 16.83 ± 0.27   108.78 ± 0.34     0.98
  *trxB*                Thioredoxin reductase (NADPH) \[EC 1.8.1.9\]                                                    17.16 ± 0.36   131.12 ± 0.88     1.20
  *NCgl0200*            NADPH:quinone reductase and related Zn-dependent oxidoreductases                                16.26 ± 0.24   109.30 ± 0.76     0.99

Data represent the average of three replicates and error bars represent standard deviation.

A total of 76 secretion and membrane transport protein encoding genes were significantly differentially expressed in *C. glutamicum* PUT-ALE (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). Of these genes, 30 were downregulated and 46 were upregulated. The differential expression may affect the metabolite transport. It has been previously shown that CgmA is a putrescine export permease and that overexpression of the *cgmA* gene increased putrescine production in *C. glutamicum* ([@B22],[@B23]). We also observed that the transcriptional of the *cgmA* gene in *C. glutamicum* PUT-ALE was significantly upregulated (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). A total of 30 transcription factors were significantly differentially expressed in *C. glutamicum* PUT-ALE (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). Of these genes, 13 were downregulated and 17 were upregulated. In addition, 378 other genes, such as unknown, transposase and ribosomal RNA genes, were significantly differentially expressed in *C. glutamicum* PUT-ALE (Supplementary Table [2](#SM1){ref-type="supplementary-material"}). Of these genes, 189 were downregulated and 189 were upregulated.

Conclusion
==========

We comparatively analyzed the transcriptomic changes in response to putrescine production in the strain *C. glutamicum* PUT-ALE. The overproduction of putrescine resulted in the transcriptional downregulation of genes involved in: glycolysis, the TCA cycle, pyruvate degradation, the biosynthesis of some amino acids, oxidative phosphorylation, vitamin biosynthesis (thiamine and vitamin 6), the metabolism of purine, pyrimidine and sulfur; and ATP-, NAD- and NADPH-consuming enzymes. The transcriptional levels of genes involved in ornithine biosynthesis and those encoding NADPH-forming enzymes were upregulated in the putrescine producer *C. glutamicum* PUT-ALE. The comparative transcriptomic analysis provided some genetic modification strategies for further improving putrescine production. Overexpression of *pyc* or its mutant *pyc458*, and replacing the *kgd* native start codon GTG with TTG further improved putrescine production. Repressing ATP- and NADPH-consuming enzyme coding gene expression via CRISPRi also enhanced putrescine production. To the best of our knowledge, this is the first report on increasing putrescine production via repressing ATP- and NADPH-consuming enzyme coding gene expression.
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